Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
INJECTION
**Dosage and administration** As with all local anaesthetics, the dose varies and depends upon the area to be anaesthetized, the vascularity of the tissues, individual tolerance and the technic used. Debilitated, elderly patients, acutely ill patients and children, should be given reduced doses commensurate with their age and physical status. **Adults** 1 cartridge for routine work. This dose may be increased for long or difficult procedures or for mixed anaesthesia (block and local). As a rule, do not exceed 3 cartridges. **Children** 6 to 14 years of age: usual dose: 1.35 mL. Do not exceed 2.7 mL 3 to 6 years of age: maximum recommended dose: 1.8 mL The product is injected either locally or in the vicinity of a dental nerve trunk. Any unused portion of a cartridge should be discarded.
INTRAMUSCULAR
Medical Information
**Indications** SCANDONEST is indicated for the production of local anaesthesia for dental procedures by infiltration injection or nerve block.
**Contraindications** - Hypersensitivity to mepivacaine (or any local anaesthesic agent of the amide type) or to any of the excipients. - Children below 3 years of age (ca. 20 kg body weight). - Severe disorders of atrioventicular conduction not compensated by pacemaker. - Poorly controlled epileptic patient.
N01BB03
mepivacaine
Manufacturer Information
n.k. luck (s) pte ltd
SPECIALITES SEPTODONT
Active Ingredients
Documents
Package Inserts
Scandonest 3 Percent Injection PI.pdf
Approved: April 14, 2021